These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32739137)

  • 1. "Cardiac allograft vasculopathy: Pathogenesis, diagnosis and therapy".
    Pighi M; Gratta A; Marin F; Bellamoli M; Lunardi M; Fezzi S; Zivelonghi C; Pesarini G; Tomai F; Ribichini F
    Transplant Rev (Orlando); 2020 Oct; 34(4):100569. PubMed ID: 32739137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation.
    Tomai F; De Luca L; Petrolini A; Di Vito L; Ghini AS; Corvo P; De Persio G; Parisi F; Pongiglione G; Giulia Gagliardi M; Prati F
    J Heart Lung Transplant; 2016 Jan; 35(1):74-79. PubMed ID: 26452998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
    Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
    JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac allograft vasculopathy can be distinguished from donor-transmitted coronary atherosclerosis by optical coherence tomography imaging in a heart transplantation recipient: double layered intimal thickness.
    Imamura T; Kinugawa K; Murasawa T; Kagami Y; Endo M; Muraoka H; Fujino T; Inaba T; Maki H; Hatano M; Kinoshita O; Nawata K; Kyo S; Komuro I; Ono M
    Int Heart J; 2014; 55(2):178-80. PubMed ID: 24632967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomography.
    Cassar A; Matsuo Y; Herrmann J; Li J; Lennon RJ; Gulati R; Lerman LO; Kushwaha SS; Lerman A
    Eur Heart J; 2013 Sep; 34(33):2610-7. PubMed ID: 23801824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical Coherence Tomography in the Assessment and Management of Cardiac Allograft Vasculopathy.
    Chatterjee A; Shanmugasundaram M; Lee KS; Kazui T; Rajapreyar IN; Acharya D
    Curr Cardiol Rep; 2024 Aug; 26(8):777-782. PubMed ID: 38864982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to Approach the Assessment of Cardiac Allograft Vasculopathy in the Modern Era: Review of Invasive Imaging Modalities.
    Javaheri A; Saha N; Lilly SM
    Curr Heart Fail Rep; 2016 Apr; 13(2):86-91. PubMed ID: 26879390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary imaging of cardiac allograft vasculopathy predicts current and future deterioration of left ventricular function in patients with orthotopic heart transplantation.
    Reddy SA; Khialani BV; Lambert B; Floré V; Brown AJ; Pettit SJ; West NE; Lewis C; Parameshwar J; Bhagra S; Kydd A; Hoole SP
    Clin Transplant; 2022 Feb; 36(2):e14523. PubMed ID: 34724254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual histology intravascular ultrasound assessment of cardiac allograft vasculopathy from 1 to 20 years after heart transplantation.
    Hernandez JM; de Prada JA; Burgos V; Sainz Laso F; Valls MF; Vilchez FG; Llano M; Ruano J; Zueco J; Colman T; Duran RM
    J Heart Lung Transplant; 2009 Feb; 28(2):156-62. PubMed ID: 19201341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy.
    Chih S; Chong AY; Erthal F; deKemp RA; Davies RA; Stadnick E; So DY; Overgaard C; Wells G; Mielniczuk LM; Beanlands RSB
    J Am Coll Cardiol; 2018 Apr; 71(13):1444-1456. PubMed ID: 29598865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between markers of plaque vulnerability in optical coherence tomography and atherosclerotic progression in adult patients with heart transplantation.
    Park KH; Sun T; Liu Z; Yang SW; Lennon RJ; Lerman LO; Kushwaha SS; Lerman A
    J Heart Lung Transplant; 2017 Feb; 36(2):185-192. PubMed ID: 27461884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression.
    Raichlin E; Bae JH; Kushwaha SS; Lennon RJ; Prasad A; Rihal CS; Lerman A
    J Am Coll Cardiol; 2009 Apr; 53(15):1279-86. PubMed ID: 19358941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac allograft vasculopathy: Insights on pathogenesis and therapy.
    Lee F; Nair V; Chih S
    Clin Transplant; 2020 Mar; 34(3):e13794. PubMed ID: 31991002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative 3D Analysis of Coronary Wall Morphology in Heart Transplant Patients: OCT-Assessed Cardiac Allograft Vasculopathy Progression.
    Chen Z; Pazdernik M; Zhang H; Wahle A; Guo Z; Bedanova H; Kautzner J; Melenovsky V; Kovarnik T; Sonka M
    Med Image Anal; 2018 Dec; 50():95-105. PubMed ID: 30253306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allograft Vasculopathy: The Achilles' Heel of Heart Transplantation.
    Chih S; Chong AY; Mielniczuk LM; Bhatt DL; Beanlands RS
    J Am Coll Cardiol; 2016 Jul; 68(1):80-91. PubMed ID: 27364054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular ultrasound for cardiac allograft vasculopathy detection.
    Mendiz OA; Gamboa P; Renedo MF; Lev GA; Favaloro LE; Bertolotti AM
    Clin Transplant; 2021 Feb; 35(2):e14167. PubMed ID: 33237578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early optical coherence tomography evaluation of donor-transmitted atherosclerosis and cardiac allograft vasculopathy: insights from a prospective, single-center study.
    Takahashi T; Kobayashi Y; Saeed O; Vukelic S; Jorde UP; Shin JJ; Patel SR
    J Heart Lung Transplant; 2023 Dec; 42(12):1678-1687. PubMed ID: 37454771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical coherence tomography and highly sensitivity troponin T for evaluating cardiac allograft vasculopathy.
    Garrido IP; García-Lara J; Pinar E; Pastor-Pérez F; Sánchez-Mas J; Valdés-Chavarri M; Pascual-Figal DA
    Am J Cardiol; 2012 Sep; 110(5):655-61. PubMed ID: 22640973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive aortic pulse pressure is linked to cardiac allograft vasculopathy after heart transplantation.
    Park HW; Ozcan I; Toya T; Ahmad A; Kanaji Y; Kushwaha SS; Lerman LO; Lerman A
    Int J Cardiol; 2023 Jan; 370():167-174. PubMed ID: 36346255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical Coherence Tomography for the Early Detection of Coronary Vascular Changes in Children and Adolescents After Cardiac Transplantation: Findings From the International Pediatric OCT Registry.
    McGovern E; Hosking MCK; Balbacid E; Voss C; Berger F; Schubert S; Harris KC
    JACC Cardiovasc Imaging; 2019 Dec; 12(12):2492-2501. PubMed ID: 30031706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.